Myeloid differentiation primary response protein 88 (MyD88) was defined as a carcinogenic gene that promoted the occurrence and development of HCC via Toll-like receptor 4 (TLR4)-MyD88-Nuclear Factor Kappa-beta (NF-κB) pathway. The gene discussed is TLR4; the disease is hepatocellular carcinoma.